This is a $1,038,529 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for "NON-MEDICAL COST OF INJURY MORBIDITY" services. The contract has an ultimate completion date of April 24, 2025.
UW is a prominent research university that has established itself as a leading institution in fields such as biomedical research, oceanography, climate science, and technology development. The university has a strong track record of executing federal contracts and grants across various government agencies, including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense.
This contract is not associated with a set-aside program. However, UW does hold an indefinite delivery/indefinite quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute for the Multi-Ethnic Study of Atherosclerosis (MESA) program, which has a potential total value of $500 million over 10 years and provides centralized omics resource DNA methylation services.
Generated 4/27/25, 12:54 AM